technetium-tc-99m-pyrophosphate and Polymyositis

technetium-tc-99m-pyrophosphate has been researched along with Polymyositis* in 2 studies

Other Studies

2 other study(ies) available for technetium-tc-99m-pyrophosphate and Polymyositis

ArticleYear
99mTechnetium pyrophosphate scintigraphy in the detection of skeletal muscle disease.
    Clinical rheumatology, 2007, Volume: 26, Issue:7

    We aimed to assess the specificity and sensitivity of (99m)technetium pyrophosphate muscle scintigraphy in the diagnostic workup of patients with suspected myopathy. We reviewed the charts of 166 patients; 52% of the subjects had myalgias, 36% had muscle weakness, 45% had an elevated serum creatine kinase (CK), and 49% had an increased C reactive protein (CRP). Scintigraphy was positive in 34 patients (20%). The test was more sensitive in the presence of muscle weakness, elevated CK, or increased CRP. The presence of myalgias did not influence the odds. Sensitivity was 60% in patients with the final diagnosis of polymyositis, dermatomyositis, or inclusion body myositis, and 70% in noninflammatory myopathies. Eight percent had false positive scintigrams. In individuals with biopsy-proven myopathy (51 subjects), the diagnostic sensitivity was 43%, and its specificity was 60%. Low positive and high negative likelihood ratios (5.0 and 0.65, respectively) document an only limited diagnostic efficiency of (99m)Tc-PYP scintigraphy in the evaluation of inflammatory and noninflammatory myopathies and suggest that the test is not helpful in the routine diagnostic workup of muscle complaints, even after a priori selection of patients for CK plus CRP abnormalities.

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Creatine Kinase; Female; Humans; Male; Middle Aged; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Pain; Polymyositis; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Pyrophosphate

2007
Cardiac and skeletal muscle scintigraphy in dermato- and polymyositis: clinical implications.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:2

    To determine the role of scintigraphy in the detection of skeletal and cardiac involvement in dermato- and polymyositis (DM/PM), we studied 30 patients with a confirmed diagnosis of DM/PM (23 females, 7 males; mean age: 35 years). Technetium-99m pyrophosphate (99mTc-PYP) and gallium-67 scans showed similar sensitivity, specificity and accuracy in the detection of skeletal muscle involvement when compared with serum enzymes (70%, 100% and 80%, respectively). Compared with the clinical parameters, 99mTc-PYP showed 70% and 67Ga 65% accuracy. Abnormal PYP cardiac uptake was observed in 57% of patients, whereas abnormal 67Ga cardiac uptake was seen in only 15%. Electrocardiography was abnormal in 40%, rest gated blood pool study in 23%, and chest X-ray in 13%. In conclusion, both 99mTc-PYP and 67Ga can be useful in the detection of the active phase of muscle disease. However, 99mTc-PYP seems to be more effective than 67Ga in the early diagnosis of cardiac involvement.

    Topics: Adolescent; Adult; Child; Clinical Enzyme Tests; Dermatomyositis; Electrocardiography; Female; Gallium Radioisotopes; Gated Blood-Pool Imaging; Heart; Humans; Male; Middle Aged; Muscle, Skeletal; Polymyositis; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Pyrophosphate

1996